These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23414447)

  • 1. High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study.
    Magnusson M; Hedblad B; Engström G; Persson M; Nilsson P; Melander O
    J Intern Med; 2013 Aug; 274(2):192-9. PubMed ID: 23414447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.
    Enhörning S; Bankir L; Bouby N; Struck J; Hedblad B; Persson M; Morgenthaler NG; Nilsson PM; Melander O
    Int J Obes (Lond); 2013 Apr; 37(4):598-603. PubMed ID: 22614056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population.
    Olynyk JK; Knuiman MW; Divitini ML; Davis TM; Beilby J; Hung J
    Am J Gastroenterol; 2009 Jul; 104(7):1715-22. PubMed ID: 19491832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C and Risk of Diabetes and the Metabolic Syndrome - Biomarker and Genotype Association Analyses.
    Magnusson M; Molvin J; Engström G; Svensson-Färbom P; Persson M; Christensson A; Nilsson P; Melander O
    PLoS One; 2016; 11(5):e0155735. PubMed ID: 27218257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome, incidence of diabetes and mortality among the elderly: the Italian Longitudinal Study of Ageing.
    Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G;
    Diabetes Metab; 2012 Apr; 38(2):135-41. PubMed ID: 22071281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study.
    Koskinen J; Magnussen CG; Würtz P; Soininen P; Kangas AJ; Viikari JS; Kähönen M; Loo BM; Jula A; Ahotupa M; Lehtimäki T; Ala-Korpela M; Juonala M; Raitakari OT
    Eur J Prev Cardiol; 2012 Dec; 19(6):1296-303. PubMed ID: 21960651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
    J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults.
    Hosseinpanah F; Asghari G; Barzin M; Golkashani HA; Azizi F
    Int J Cardiol; 2013 Sep; 168(1):369-74. PubMed ID: 23041003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the suita study.
    Kokubo Y; Okamura T; Yoshimasa Y; Miyamoto Y; Kawanishi K; Kotani Y; Okayama A; Tomoike H
    Hypertens Res; 2008 Nov; 31(11):2027-35. PubMed ID: 19098374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperuricemia predicts future metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan.
    Nagahama K; Inoue T; Kohagura K; Ishihara A; Kinjo K; Ohya Y
    Hypertens Res; 2014 Mar; 37(3):232-8. PubMed ID: 24173358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between cystatin C and incident type 2 diabetes is related to central adiposity.
    Reutens AT; Bonnet F; Lantieri O; Roussel R; Balkau B;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1820-9. PubMed ID: 23291367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients.
    Lee SH; Park SA; Ko SH; Yim HW; Ahn YB; Yoon KH; Cha BY; Son HY; Kwon HS
    Metabolism; 2010 Feb; 59(2):241-6. PubMed ID: 19765773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.
    Athyros VG; Bouloukos VI; Pehlivanidis AN; Papageorgiou AA; Dionysopoulou SG; Symeonidis AN; Petridis DI; Kapousouzi MI; Satsoglou EA; Mikhailidis DP;
    Diabetes Obes Metab; 2005 Jul; 7(4):397-405. PubMed ID: 15955126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between red meat consumption and metabolic syndrome in a Mediterranean population at high cardiovascular risk: cross-sectional and 1-year follow-up assessment.
    Babio N; Sorlí M; Bulló M; Basora J; Ibarrola-Jurado N; Fernández-Ballart J; Martínez-González MA; Serra-Majem L; González-Pérez R; Salas-Salvadó J;
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):200-7. PubMed ID: 20875949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
    Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.